Amphion Innovations plc
Change of Adviser

London and New York, 6 January 2011– Amphion Innovations plc (AIM: AMP), the developer of medical and technology businesses, is pleased to announce the appointment of Seymour Pierce Limited as its Nominated Adviser and Broker, with immediate effect.


Amphion Innovations plc
Charlie Morgan
+44 779 953 6043

Seymour Pierce Limited (Nominated Adviser)
Freddy Crossley
+44 (0) 20 7107 8000

Mark Percy

Corporate Broking
Marianne Woods

Cardew Group
Tim Robertson/ Jamie Milton
+44 20 7930 0777

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number that grows rapidly each year.

On the web: